MANKIND₹2,212.60-2.77%
Value & Investment Index
VIIVII Detail
90 days · zone the stock traded inMultiples vs Peers
Quality Scores
Versus Its Own History
P/E · P/B percentile bandsScenario analysis
stated assumptions, shown workingsMANKIND valuation summary
Mankind Pharma Ltd trades at 45.3 times trailing earnings. Return on equity is 13.8% and return on capital employed is 13.7%. The dividend yield is 0.04%.
| P/E | 45.3 |
|---|---|
| ROE | 13.8% |
| ROCE | 13.7% |
| Dividend yield | 0.04% |